BioSpace News Archive

Cognito Therapeutics today announced that Brent Vaughan, CEO, will participate in a fireside chat at the BTIG Biotechnology Conference 2021 on Monday, August 9, 2021 from 11:00-11:25 am ET.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of retinitis pigmentosa (RP).

BeyondSpring, a global pharmaceutical company focused on the development of cancer therapeutics, announced the positive topline data of DUBLIN-3 registrational trial in plinabulin in combination with docetaxel to treat 2nd and 3rd line NSCLC compared to docetaxel alone.

908 Devices Inc. today reported financial results for the quarter ended June 30, 2021.

Exicure , Inc. today announced that CEO David Giljohann will present at the BTIG Virtual Biotechnology Conference on Monday, August 9, 2021 at 2:30pm ET. Exicure will also host 1x1 investor meetings during the conference.

Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through complementary regulatory T cell (T reg ) therapy and effector T cell (T eff ) conditioning

Graybug Vision, Inc. today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a panel discussion titled “Goldeneye” at the Wedbush PacGrow Healthcare Conference on Wednesday, August 11, 2021 at 9:45 a.m. ET / 6:45 a.m. PT.

PanTher Therapeutics announced today that it received approval from the Human Research Ethics Committee (HREC) to open a Phase 1 clinical trial of PTM-101 in Australia. PTM-101 is being developed for the treatment of pancreatic cancer.

EDAP TMS SA, the global leader in robotic energy-based therapies, reports select preliminary unaudited second quarter financial and operating results.

Eyenovia, Inc., a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology, announced that the Company will release financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021, after the market close.